Antibody assays and thresholds can be product- and protocol-specific. Ask which test is being used, whether repeat testing is allowed, and whether a result affects only one study or broader eligibility.
What this means in real life
Antibody tests estimate whether the immune system may react to a viral vector or other therapy component. Assays, cutoffs and sample handling differ by product and protocol, so a result is not a universal pass or fail for every gene-therapy study. Antibody levels can also change, and some protocols allow repeat testing while others do not.
Ask for the name of the assay, the numeric result if available, the protocol threshold and whether the result is neutralizing or binding antibody. Confirm whether a positive result excludes only the current study/product, whether retesting is allowed and when, and whether any intervention to lower antibodies is investigational.
Do not pursue unproven immune treatments or intentionally seek infection/exposure to manipulate a test. A positive screening result can be deeply disappointing; the center should explain other treatment and research options without making promises about future eligibility.
A practical checklist
- ✓
Identify the vector or target and exact assay used.
- ✓
Request the result and protocol cutoff in writing.
- ✓
Ask whether the sample can be repeated and what timing rules apply.
- ✓
Clarify whether the result affects one product or broader options.
- ✓
Avoid unapproved antibody-lowering schemes outside a regulated study.
Questions to bring with you
Use these at the clinic, school meeting, equipment evaluation, program interview or benefits call. Write down the answers and who owns the next step.
- What exactly was measured?
- How reliable and reproducible is this assay?
- Can illness, vaccination or timing affect the result?
- Is retesting permitted?
- Which non-AAV or other-vector options remain available?
Important context
Individual needs, eligibility and safety can differ. Confirm the plan with the relevant Duchenne-experienced clinician, therapist, school team or program before acting.
Sources used for this guide
Direct links are included so families can check the original guidance and bring it to qualified professionals.
Content review: July 18, 2026. Medical labels, trials, benefits and programs can change after publication.
Did this article answer the question?
A thumbs-down sends the article to the private administrator dashboard for review.